[ad_1]
The government has obtained an additional two million doses of the Modern COVID-19 vaccine, which according to trials is 95% effective.
The announcement occurred as the government appointed a minister, Nadhim Zahawi, responsible for the national deployment of the jabs.
Use the Chrome browser for a more accessible video player
Modern vaccine: ‘No evidence of waning immunity’
The total number of Modern vaccine doses ordered from the American pharmaceutical company now that’s seven million, enough for 3.5 million people in the UK.
Doses of the jab could begin in the spring, but it has not yet been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA).
the Oxford and AstraZeneca jab it could be implemented in a few weeks if approved by the MHRA, and the UK has close to 100 million doses on request.
There are also 40 million doses from Pfizer and BioNTech vaccine on request, which has also been shown to be around 95% effective.
Zahawi, who is also a business minister, said he was “delighted” to be in charge of launching the vaccine when it happens.
“A great responsibility and a great operational challenge, but absolutely committed to making sure that we can implement vaccines quickly, saving lives and livelihoods,” he tweeted.
Kate Bingham, who chairs the Government Vaccine Task Force, said: “Since its inception in June, one of the most important stated goals of the Vaccine Task Force has been to ensure access to the most promising vaccines across a wide range technologies, thus increasing the chances of having a safe and effective prevention against COVID-19 as soon as possible.
“Moderna’s vaccine was an important addition to our portfolio and obtaining an additional two million doses adds to the protection we can provide to the public to end the pandemic.”
:: Subscribe to the daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker
Health Secretary Matt Hancock said: “Every week, we receive more positive news about the range of vaccines in development and, thanks to the work of our task force, the UK has booked over hundreds of millions of doses from companies. more advanced in their work.
“With a wide range of vaccine candidates in our portfolio, we are ready to roll out a vaccine should they receive approval from our drug regulator, starting with those who will benefit the most.”
